产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
A999041 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pidilizumab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pidilizumab), |
|||
A999042 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pimivalimab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (pimivalimab), |
|||
A999043 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (prolgolimab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (prolgolimab), |
|||
A999044 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (retifanlimab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (retifanlimab), |
|||
A999045 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sasanlimab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sasanlimab), |
|||
A999046 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (serplulimab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (serplulimab), |
|||
A999047 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sintilimab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (sintilimab), |
|||
A999048 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (spartalizumab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (spartalizumab), |
|||
A999049 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (tislelizumab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (tislelizumab), |
|||
A999050 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (toripalimab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (toripalimab), |
|||
A999051 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (UCB patent anti-PD-1), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (UCB patent anti-PD-1), |
|||
A999052 | Anti-PDCD1 / PD-1 / CD279 Reference Antibody (zimberelimab), Anti-PDCD1 / PD-1 / CD279 Reference Antibody (zimberelimab), |
|||
A999053 | Anti-PDGFB Reference Antibody (MOR-8457), Anti-PDGFB Reference Antibody (MOR-8457), |
|||
A999054 | Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics patent anti-PDGF-C), Anti-PDGFC / VEGFE Reference Antibody (Thrombogenics patent anti-PDGF-C), |
|||
A999055 | Anti-PDGFRA / CD140a Reference Antibody (olaratumab), Anti-PDGFRA / CD140a Reference Antibody (olaratumab), |
|||
A999056 | Anti-PDGFRA / CD140a Reference Antibody (tovetumab), Anti-PDGFRA / CD140a Reference Antibody (tovetumab), |
|||
A999057 | Anti-PDGFRB / CD140b Reference Antibody (IMC-2C5), Anti-PDGFRB / CD140b Reference Antibody (IMC-2C5), |
|||
A999058 | Anti-PDGFRB / CD140b Reference Antibody (rinucumab), Anti-PDGFRB / CD140b Reference Antibody (rinucumab), |
|||
A999059 | Anti-PGLYRP1 / PGRP-S Reference Antibody (Novo Nordisk patent anti-PGLYRP1), Anti-PGLYRP1 / PGRP-S Reference Antibody (Novo Nordisk patent anti-PGLYRP1), |
|||
A999060 | Anti-Phosphatidylserine Reference Antibody (bavituximab), Anti-Phosphatidylserine Reference Antibody (bavituximab), |